US stock · Healthcare sector · Biotechnology
R
Rigel Pharmaceuticals, Inc.
RIGL
NASDAQ1.40
USD
- -
(- -)
Market Closed
-5.14P/E
-11Forward P/E
-0.21P/E to S&P500
243.134MMarket CAP
- -Div Yield
Scale: |
View:
To be able to download in Excel format or copy to your clipboard 24 years of financial statements, we ask you for a tweet about us. This will help us provide a good service in the future. You need to make a tweet only once a month, and you're free to write whatever you want.
Just mention roic.ai in your tweet (or click here) and type in your nickname in the field below.
Your Twitter username
Currency: USD, in millions
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Income Statement
Revenue
9
13
15
16
11
5
17
33
13
- -
1
125
5
2
7
8
29
20
4
45
59
109
149
120
COGS
(2)
(8)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0
1
1
1
2
Gross Profit
11
21
15
16
11
5
17
33
13
- -
1
125
5
2
7
8
29
- -
- -
44
58
108
148
118
Gross Profit Ratio
121.22%
157.17%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
- -
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
- -
- -
99.36%
98.47%
99.18%
99.27%
98.55%
Operating Expenses
23
46
40
53
52
62
64
77
92
137
112
90
91
102
95
99
81
84
84
117
127
137
157
174
R&D Expenses
17
32
32
43
43
49
52
57
70
110
91
64
69
79
75
68
63
63
46
47
53
60
65
60
Selling, G&A Exp.
4
7
8
9
9
13
12
20
22
27
21
25
22
23
20
32
18
21
38
70
75
77
92
112
General and Admin. Exp.
- -
- -
8
9
9
13
12
20
22
27
21
25
22
23
20
32
18
21
38
70
75
- -
- -
- -
Selling and Marketing Exp.
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Expenses
2
8
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
COGS and Expenses
21
39
40
53
52
62
64
77
92
137
112
90
91
102
95
99
81
84
84
117
128
138
158
176
Interest Income
- -
1
2
1
0
1
3
6
5
4
1
0
0
1
0
0
0
0
1
2
3
1
0
1
Interest Expense
- -
1
1
1
1
0
0
0
0
0
0
0
0
- -
- -
- -
- -
- -
- -
- -
0
1
5
4
Depreciation and Amortization
2
8
7
6
3
2
1
1
1
1
1
1
2
2
3
2
1
1
0
1
1
1
1
1
EBITDA
(10)
(17)
(16)
(30)
(37)
(54)
(44)
(36)
(73)
(131)
(110)
39
(84)
(96)
(86)
(89)
(50)
(68)
(78)
(70)
(66)
(28)
(11)
(54)
EBITDA ratio
(116.43)%
(127.63)%
(106.14)%
(192.15)%
(338.72)%
(1,131.59)%
(265.04)%
(107.34)%
(577.04)%
(Infinity)%
(14,671.20)%
31.44%
(1,768.27)%
(4,284.76)%
(1,208.88)%
(1,073.32)%
(173.13)%
(334.96)%
(1,728.97)%
(157.02)%
(111.11)%
(25.49)%
(7.56)%
(44.80)%
Operating Income
(12)
(26)
(25)
(37)
(41)
(57)
(48)
(43)
(80)
(137)
(112)
35
(86)
(99)
(89)
(91)
(52)
(70)
(80)
(73)
(69)
(29)
(12)
(56)
Operating Income ratio
(134.46)%
(192.96)%
(163.11)%
(234.46)%
(369.31)%
(1,201.50)%
(289.98)%
(128.60)%
(631.17)%
(Infinity)%
(14,938.27)%
28.25%
(1,818.27)%
(4,416.76)%
(1,251.31)%
(1,106.05)%
(179.07)%
(342.15)%
(1,775.56)%
(163.30)%
(116.53)%
(26.67)%
(8.37)%
(46.20)%
Total Other Income Exp.(Gains)
- -
- -
- -
- -
(0)
(0)
- -
- -
- -
4
0
3
0
1
0
0
0
1
2
2
2
(1)
(5)
(3)
Income Before Tax
- -
- -
- -
- -
- -
- -
- -
- -
- -
(132)
(112)
38
(86)
(99)
(89)
(91)
(51)
(69)
(78)
(70)
(67)
(30)
(17)
(59)
Income Before Tax ratio
- -
- -
- -
- -
- -
- -
- -
- -
- -
(Infinity)%
(14,885.33)%
30.31%
(1,809.96)%
(4,392.89)%
(1,245.13)%
(1,101.92)%
(178.11)%
(339.58)%
(1,739.34)%
(158.35)%
(112.83)%
(27.38)%
(11.60)%
(48.71)%
Income Tax Expense (Gain)
- -
- -
- -
- -
- -
- -
- -
- -
- -
(0)
(0)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
Net Income
(12)
(25)
(24)
(37)
(41)
(56)
(45)
(38)
(74)
(132)
(112)
38
(86)
(99)
(89)
(91)
(51)
(69)
(78)
(70)
(67)
(30)
(18)
(59)
Net Income Ratio
(137.64)%
(191.86)%
(155.56)%
(234.55)%
(372.65)%
(1,188.57)%
(273.85)%
(112.44)%
(589.46)%
(Infinity)%
(14,872.93)%
30.31%
(1,809.96)%
(4,392.89)%
(1,245.13)%
(1,101.92)%
(178.11)%
(339.58)%
(1,739.34)%
(158.35)%
(112.83)%
(27.38)%
(12.00)%
(48.71)%
EPS
(355.63)
(31.43)
(5.76)
(7.38)
(3.62)
(3.12)
(2.07)
(1.51)
(2.57)
(3.67)
(2.73)
0.73
(1.36)
(1.32)
(1.02)
(1.04)
(0.58)
(0.73)
(0.62)
(0.44)
(0.40)
(0.18)
(0.11)
(0.34)
EPS Diluted
(355.63)
(31.43)
(5.76)
(7.38)
(3.62)
(3.12)
(2.07)
(1.51)
(2.57)
(3.67)
(2.73)
0.72
(1.36)
(1.32)
(1.02)
(1.04)
(0.58)
(0.73)
(0.62)
(0.44)
(0.40)
(0.18)
(0.11)
(0.34)
Weighted Avg. Shares Outs.
0
1
4
5
11
18
22
25
29
36
41
52
63
75
87
88
88
94
126
161
167
169
169
172
Weighted Avg. Shares Outs. Dil.
0
1
4
5
11
18
22
25
29
36
41
53
63
75
87
88
88
94
126
161
167
169
169
172
SEC Link
Balance Sheet
Cash and Cash Equivalents
6
49
11
27
10
10
77
48
45
46
15
9
19
33
21
15
43
18
38
76
23
30
19
24
Short-Term Investments
- -
4
22
1
37
61
61
57
64
88
119
168
229
265
191
128
83
57
77
52
76
27
106
34
Cash & Short-Term Investments
6
53
33
27
47
71
138
104
108
134
133
177
248
298
212
143
126
75
116
129
98
57
125
58
Net Receivables
2
1
1
8
1
1
2
1
0
- -
- -
- -
- -
- -
6
6
0
- -
- -
4
10
16
15
40
Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
2
7
9
Other Current Assets
0
1
2
2
2
2
3
2
2
4
3
3
3
4
2
2
3
1
2
3
9
14
7
8
Total Current Assets
9
55
37
37
50
74
143
108
111
138
136
180
250
302
220
151
129
76
117
137
119
89
154
116
PP&E
8
9
8
5
4
3
3
3
3
4
2
5
5
6
4
3
2
1
1
1
28
21
12
3
Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
15
Goodwill and Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
15
Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Non-Current Assets
0
0
1
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Total Non-Current Assets
9
10
10
7
5
5
5
5
5
6
5
7
7
8
6
4
3
2
2
2
29
21
13
18
Other Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
17
64
46
44
56
79
148
113
116
144
141
187
257
310
226
154
132
78
119
139
148
110
167
134
Accounts Payable
1
1
2
3
1
2
2
2
4
6
3
1
2
2
4
2
3
6
3
6
4
4
4
23
Short-Term Debt
- -
- -
3
3
2
1
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
9
10
1
Tax Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Revenue
- -
- -
3
4
2
4
16
3
- -
3
- -
- -
0
1
- -
- -
13
- -
- -
1
25
3
3
1
Other Current Liabilities
9
7
2
3
2
4
5
5
11
14
15
10
10
10
6
12
18
17
16
20
29
25
47
40
Total Current Liabilities
10
8
10
14
8
11
24
11
16
24
18
11
12
12
10
14
34
23
18
28
58
41
64
65
Long-Term Debt
5
6
4
- -
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
10
30
21
1
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
12
9
9
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Non-Current Liabilities
1
1
3
5
7
15
15
15
17
13
1
0
0
9
8
12
7
1
0
0
24
5
53
82
Total Non-Current Liabilities
7
7
7
5
7
15
15
15
17
16
13
9
9
9
8
12
7
1
0
1
36
36
73
83
Other Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Lease Obligations
- -
- -
- -
2
1
1
1
1
1
- -
2
1
- -
- -
- -
- -
- -
- -
- -
- -
27
19
11
2
Total Liabilities
16
15
18
19
16
27
39
26
34
40
31
21
21
21
18
26
40
23
18
29
94
76
137
148
Preferred Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
(29)
(54)
(78)
(115)
(156)
(212)
(258)
(295)
(369)
(502)
(613)
(575)
(661)
(760)
(849)
(940)
(992)
(1,061)
(1,139)
(1,209)
(1,276)
(1,306)
(1,324)
(1,382)
Other Compreh. Income(Loss)
(3)
(6)
(10)
(15)
(14)
(11)
(12)
(13)
(15)
(15)
(16)
(16)
(18)
(20)
(22)
(23)
(18)
(19)
(12)
(13)
(13)
(0)
(0)
(0)
Other Total Stockhold. Equity
33
109
117
155
210
276
378
396
466
621
739
758
916
1,069
1,080
1,091
1,101
1,135
1,252
1,332
1,343
1,340
1,354
1,369
Total Stockholders Equity
1
49
29
25
40
52
109
87
82
104
110
166
236
289
208
128
91
55
101
110
54
34
30
(14)
Total Liab.&Stockhold. Equity
17
64
46
44
56
79
148
113
116
144
141
187
257
310
226
154
132
78
119
139
148
110
167
134
Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities & Equity
17
64
46
44
56
79
148
113
116
144
141
187
257
310
226
154
132
78
119
139
148
110
167
134
SEC Link
Cash Flow Statement
Net Income
(12)
(25)
(24)
(37)
(41)
(56)
(45)
(38)
(74)
(132)
(112)
38
(86)
(99)
(89)
(91)
(51)
(69)
(78)
(70)
(67)
(30)
(18)
(59)
Depreciation and Amortization
2
8
7
6
3
2
1
1
1
1
1
1
2
2
3
2
1
1
0
1
1
1
1
1
Deferred Income Tax
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Stock Based Compensation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
13
16
13
13
7
10
7
7
6
8
9
7
9
12
Change in Working Capital
1
(1)
2
(3)
5
13
11
(12)
9
4
(6)
(9)
1
(1)
(7)
(0)
19
(16)
(5)
4
17
(30)
10
(29)
Accounts Receivable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(6)
- -
6
0
- -
(4)
(6)
(6)
1
(25)
Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(1)
(0)
(0)
(5)
(2)
Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(3)
(2)
0
0
2
(2)
1
3
(3)
4
(2)
(0)
0
4
Other Working Capital
(1)
47
26
22
42
63
119
(13)
4
(1)
(4)
(3)
3
(1)
(5)
(1)
12
(21)
(4)
5
28
(23)
1
- -
Other Non-Cash Items
2
7
(1)
(0)
1
2
(2)
13
12
24
- -
- -
- -
- -
- -
9
(0)
1
(1)
(1)
(1)
(0)
3
- -
Cash Provided by Operating Activities
(8)
(12)
(16)
(35)
(32)
(38)
(35)
(36)
(52)
(104)
(103)
47
(69)
(85)
(86)
(70)
(23)
(76)
(78)
(59)
(42)
(52)
6
(74)
CAPEX
(7)
(4)
(3)
(2)
(1)
(2)
(2)
(1)
(1)
(3)
(0)
(4)
(2)
(3)
(1)
(0)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
Acquisitions Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Purchases of Investments
- -
(4)
(48)
(27)
(42)
(96)
(90)
(85)
(134)
(195)
(170)
(266)
(476)
(475)
(309)
(219)
(152)
(103)
(117)
(78)
(145)
(82)
(141)
(29)
Sales/Maturities of Investments
- -
- -
30
48
6
72
89
90
128
170
139
216
415
440
382
282
197
129
97
104
123
130
62
101
Other Investing Activities
- -
- -
- -
- -
0
- -
- -
0
0
0
(0)
(4)
(2)
(3)
(1)
(0)
(0)
(1)
1
(1)
(1)
(1)
(1)
1
Cash Used for Investing Activities
(7)
(8)
(21)
19
(37)
(26)
(2)
4
(8)
(27)
(31)
(53)
(63)
(39)
72
63
45
25
(19)
25
(24)
47
(80)
73
Debt Repayment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(1)
(1)
(1)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock Issued
6
61
1
32
55
66
104
3
57
130
104
2
143
139
1
1
5
24
114
67
- -
- -
- -
- -
Common Stock Repurchased
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
5
- -
Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Financing Activities
5
1
(1)
(2)
(2)
(1)
0
0
(1)
2
- -
- -
- -
- -
- -
- -
2
2
4
5
11
13
58
7
Cash Used/Provided by Financing Activities
11
62
(0)
30
53
65
104
3
57
132
102
1
142
139
1
1
7
25
118
72
11
13
63
7
Effect of Forex Changes on Cash
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Change In Cash
(4)
43
(38)
15
(17)
1
66
(29)
(3)
2
(31)
(6)
10
15
(13)
(6)
28
(26)
21
38
(54)
8
(11)
6
Cash at the End of Period
6
49
11
27
10
10
77
48
45
46
15
9
19
33
21
15
43
18
38
76
23
30
19
24
Cash at the Beginning of Period
9
6
49
11
27
10
10
77
48
45
46
15
9
19
33
21
15
43
18
38
76
23
30
19
Free Cash Flow
(15)
(15)
(19)
(36)
(34)
(40)
(37)
(37)
(53)
(106)
(103)
43
(72)
(89)
(87)
(70)
(24)
(77)
(78)
(60)
(43)
(53)
5
(74)
SEC Link
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -